These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20569435)

  • 41. Gram-negative bacillary bacteremia in human immunodeficiency virus type 1-infected children.
    Rongkavilit C; Rodriguez ZM; Gómez-Marín O; Scott GB; Hutto C; Rivera-Hernandez DM; Mitchell CD
    Pediatr Infect Dis J; 2000 Feb; 19(2):122-8. PubMed ID: 10693998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparisons of clinical features and outcomes between Elizabethkingia meningoseptica and other glucose non-fermenting Gram-negative bacilli bacteremia in adult ICU patients.
    Chen WC; Chen YW; Ko HK; Yu WK; Yang KY
    J Microbiol Immunol Infect; 2020 Apr; 53(2):344-350. PubMed ID: 30274894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiology and clinical outcomes of multidrug-resistant, gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period.
    Folgori L; Livadiotti S; Carletti M; Bielicki J; Pontrelli G; Ciofi Degli Atti ML; Bertaina C; Lucignano B; Ranno S; Carretto E; Muraca M; Sharland M; Bernaschi P
    Pediatr Infect Dis J; 2014 Sep; 33(9):929-32. PubMed ID: 24642515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia].
    Saldías P F; Reyes B T; Sáez B J; Rain M C; Illanes C P; Briceño V C; Díaz P O
    Rev Med Chil; 2015 May; 143(5):553-61. PubMed ID: 26203565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.
    Marschall J; Agniel D; Fraser VJ; Doherty J; Warren DK
    J Antimicrob Chemother; 2008 Jun; 61(6):1376-83. PubMed ID: 18344548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia.
    Leung CH; Liu CP
    J Microbiol Immunol Infect; 2019 Aug; 52(4):654-662. PubMed ID: 31446929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive scoring models for persistent gram-negative bacteremia that reduce the need for follow-up blood cultures: a retrospective observational cohort study.
    Jung J; Song KH; Jun KI; Kang CK; Kim NH; Choe PG; Park WB; Bang JH; Kim ES; Park SW; Kim NJ; Oh MD; Kim HB
    BMC Infect Dis; 2020 Sep; 20(1):680. PubMed ID: 32942993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of bacteremia on lipoprotein concentrations and patient's outcome: a retrospective analysis.
    Pizzini A; Kurz K; Orth-Hoeller D; Fille M; Rabensteiner J; Lunger F; Lunger L; Tschurtschenthaler C; Tancevski I; Krause R; Lass-Floerl C; Weiss G; Bellmann-Weiler R
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1279-1286. PubMed ID: 30982158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
    von Dach E; Albrich WC; Brunel AS; Prendki V; Cuvelier C; Flury D; Gayet-Ageron A; Huttner B; Kohler P; Lemmenmeier E; McCallin S; Rossel A; Harbarth S; Kaiser L; Bochud PY; Huttner A
    JAMA; 2020 Jun; 323(21):2160-2169. PubMed ID: 32484534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
    Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
    J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community-acquired Staphylococcus aureus bacteremia: Studies of risk and prognosis with special attention to diabetes mellitus and chronic heart failure.
    Smit J
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for in-hospital mortality in patients with type 2 diabetes complicated by community-acquired Klebsiella pneumoniae bacteremia.
    Huang CH; Tsai JS; Chen IW; Hsu BR; Huang MJ; Huang YY
    J Formos Med Assoc; 2015 Oct; 114(10):916-22. PubMed ID: 26315482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical prediction rules for bacteremia and in-hospital death based on clinical data at the time of blood withdrawal for culture: An evaluation of their development and use.
    Nakamura T; Takahashi O; Matsui K; Shimizu S; Setoyama M; Nakagawa M; Fukui T; Morimoto T
    J Eval Clin Pract; 2006 Dec; 12(6):692-703. PubMed ID: 17100868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital.
    Tian H; Chen L; Wu X; Li F; Ma Y; Cai Y; Song S
    Dig Dis Sci; 2020 Jul; 65(7):2079-2088. PubMed ID: 31691173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between HACEK bacteraemia and endocarditis.
    Sen Yew H; Chambers ST; Roberts SA; Holland DJ; Julian KA; Raymond NJ; Beardsley J; Read KM; Murdoch DR
    J Med Microbiol; 2014 Jun; 63(Pt 6):892-895. PubMed ID: 24681996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis.
    Cain SE; Kohn J; Bookstaver PB; Albrecht H; Al-Hasan MN
    Antimicrob Agents Chemother; 2015 Jan; 59(1):245-50. PubMed ID: 25348527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gram-negative bacteremia as a clinical marker of occult malignancy.
    Søgaard KK; Farkas DK; Søgaard M; Schønheyder HC; Thomsen RW; Sørensen HT
    J Infect; 2017 Feb; 74(2):153-162. PubMed ID: 27838520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients--risk factors and outcomes.
    Haeusler GM; Mechinaud F; Daley AJ; Starr M; Shann F; Connell TG; Bryant PA; Donath S; Curtis N
    Pediatr Infect Dis J; 2013 Jul; 32(7):723-6. PubMed ID: 23838774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli.
    Al-Hasan MN; Wilson JW; Lahr BD; Thomsen KM; Eckel-Passow JE; Vetter EA; Tleyjeh IM; Baddour LM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1386-94. PubMed ID: 19164144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.